NASDAQ:APRE

Aprea Therapeutics Stock Predictions

etoro logo Buy APRE
*Your capital is at risk
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

APRE Prediction Chart

APRE Predictions History

Latest community submissions for APRE.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 27, 2026 $0.95 +2.64% $0.86 X 89.16% 0
Apr 27, 2026 Bearish $0.86 V 1
Apr 21, 2026 $0.94 -4.00% $0.91 V 96.20% 1
Apr 21, 2026 $0.94 -4.00% $0.91 V 96.20% 1
Apr 21, 2026 $0.96 -2.50% $0.91 V 94.58% 1
Apr 21, 2026 Bearish $0.91 V 1
Mar 11, 2026 $0.87 +4.23% $0.787 X 89.94% 0
Mar 11, 2026 $0.85 +2.65% $0.787 X 91.62% 0
Mar 11, 2026 Bullish $0.787 X 0
Mar 3, 2026 $0.85 -4.52% $0.85 V 99.54% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for APRE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT APREA THERAPEUTICS INC.
Aprea Therapeutics
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE